Source comparison
MK-677 Animal vs Human Research: Protocol Comparison
Typical Dose 10–50mg/kg body weight 10–25mg total daily dose Rodent doses 5–10× higher when scaled allometrically; direct mg/kg comparison is invalid Dosing Duration 3–28 days (acute to short-term) 8 weeks to 2 years (chronic) Rodent studies miss long-term met
This comparison does not assign a generated winner or score.
- Typical Dose
- 10–50mg/kg body weight
- 10–25mg total daily dose
- Rodent doses 5–10× higher when scaled allometrically; direct mg/kg comparison is invalid
- Dosing Duration
- 3–28 days (acute to short-term)
- 8 weeks to 2 years (chronic)
- Rodent studies miss long-term metabolic effects (insulin resistance, IGF-1 feedback)
- GH Response Pattern
- Acute spike (300–600% above baseline) within 90 min
- Sustained elevation (50–90% AUC increase) over 24 hours
- Different pharmacokinetic profiles; rodent spikes don't predict human steady-state levels
- Metabolic Tracking
- Rarely measured beyond glucose/insulin snapshots
- Fasting glucose, HOMA-IR, lipid panels tracked longitudinally
- Human trials reveal insulin resistance risk not captured in short rodent protocols
- Body Composition
- Lean mass +8–15% over 4–6 weeks
- Lean mass +1–3% over 12 months
- Rodent results overestimate human anabolic response due to species growth rate differences
- Professional Assessment
- Best for mechanism validation and tissue-specific effects
- Essential for safety, dosing, and real-world efficacy assessment
- Preclinical data guides hypotheses; human trials determine clinical viability